Skip to main content
Uncategorized

IRB Barcelona expands its cancer program with the hiring of Angel Nebreda from CNIO

By 20 de July de 2010November 18th, 2020No Comments
< Back to news
 20.07.2010

IRB Barcelona expands its cancer program with the hiring of Angel Nebreda from CNIO

After six years at the Centro Nacional de Investigaciones Oncológicas (CNIO) (Spanish National Cancer Research Centre) in Madrid, Nebreda and his team have moved to the capital of Catalonia to join the Oncology programme, in which they will set up the "Signalling and Cell Cycle" lab, the fourth at IRB Barcelona –located at the Barcelona Science Park– devoted exclusively to cancer.

Most of the studies performed by Nebreda centre on the protein p38 MAPK and its implications in cancer. p38 is present in all cells of an organism where it participates in multiple processes, including blocking the development of cancer and controlling the proliferation and differentiation of stem cells in lung tissue.

In 2007 Nebreda’s group discovered that lung tumours develop more quickly in mice when p38 was inactivated . The results from several studies were published in Nature Genetics and Cancer Cell, two of the biomedical journals with the highest impact factors.

More information